| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/19/2001 | WO2001004271A3 Respiratory syncytial viruses expressing immune modulatory molecules |
| 07/19/2001 | WO2001002020A3 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 07/19/2001 | WO2001001998A3 Treatment of endometriosis with antileukoprotease |
| 07/19/2001 | WO2000077043A3 Dna vaccines for pets and sport animals |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000071703A3 Inhibition of histone deacetylase |
| 07/19/2001 | WO2000044782A3 Ewing's tumour antigen, nucleic acid and antibodies |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008882 Process of delivering a polynucleotide into a parenchymal cell |
| 07/19/2001 | US20010008881 Method for the augmentation of gene expression |
| 07/19/2001 | US20010008772 Lipid, nucleic acid complex |
| 07/19/2001 | DE19960206A1 Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung Complexation of RNA with polyethyleneimine for their stabilization and cellular infiltration |
| 07/19/2001 | DE10001390A1 Zelllinie zur Herstellung und Produktion von Schafadenovirusvektoren Cell line for the manufacture and production of Schafadenovirusvektoren |
| 07/19/2001 | CA2397374A1 Innate immunity-stimulating compositions of cpg and saponin and methods thereof |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397207A1 Novel stra6 polypeptides |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2397003A1 Cell line for preparing and producing ovine adenovirus vectors |
| 07/19/2001 | CA2396996A1 Genetically modified fibroblast cell |
| 07/19/2001 | CA2396348A1 Cardiac-cell specific enhancer elements and uses thereof |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/18/2001 | EP1115886A2 Secreted renilla luciferase |
| 07/18/2001 | EP1115879A1 Retroviral particles protected against complement mediated destruction |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115871A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 07/18/2001 | EP1115865A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 07/18/2001 | EP1115863A1 Ucp4 |
| 07/18/2001 | EP1115859A2 Hairpin hybridizer molecules for modulation of gene expression |
| 07/18/2001 | EP1115857A1 Use of specific hybrid promoters for controlling tissue expression |
| 07/18/2001 | EP1115851A1 Method of screening for large offspring syndrome |
| 07/18/2001 | EP1115849A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115733A1 Sequences characteristic of hypoxia-regulated gene transcription |
| 07/18/2001 | EP1115452A1 Systems and methods for treating ischemia |
| 07/18/2001 | EP0846170B1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 07/18/2001 | CN1304454A Novel nucleic acids and polypeptides related to farnesyl-directed endopeptidase |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304452A Attenuated pestiviruses |
| 07/18/2001 | CN1304451A Fusion proteins of i(mycobacterium tuberuculosis) antigens and their uses |
| 07/18/2001 | CN1304449A Novel angiotensin receptor, production and use thereof |
| 07/18/2001 | CN1304446A Poly (ADP-ribose) polymerse gene |
| 07/18/2001 | CN1304442A Delivery of proteins into eukaryotic cells with recombinant Yersinia |
| 07/18/2001 | CN1304316A Adenovirus vector containing heterologous peptide epitope in HI loop of fiber knob |
| 07/18/2001 | CN1303946A Novel human ATP synthase and its code sequence |
| 07/18/2001 | CN1303936A Novel polypeptide-zinc finger protein 56 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303865A Novel polypeptide-human vasicentric protein 69 and polynucleotide for coding said polypeptide |
| 07/17/2001 | US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents |
| 07/17/2001 | US6262247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262242 Tumor suppressor designated TS10Q23.3 |
| 07/17/2001 | US6262241 Antisense compounds which cleave phosphorodiester bonds and improve pharmacodynamic and pharmacokinetic properties of oligonucleotides, useful in diagnosing diseases |
| 07/17/2001 | US6262172 Method for preparing a carbonized resin DNA immunoadsorbent |
| 07/17/2001 | US6262036 Method for inhibiting RNA translation using chimeric oligonucleoside compounds |
| 07/17/2001 | US6262035 Gene replacement therapy for muscular dystrophy |
| 07/17/2001 | US6262034 Polymeric gene delivery system |
| 07/17/2001 | US6262033 Remedy for diseases associated with NF-κB |
| 07/17/2001 | US6262032 Method of destroying hyperproliferative cells by combined p53 and taxoid treatment |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6262016 Transferrin receptor genes |
| 07/17/2001 | US6261840 Nucleotide sequences for gene expression inhibition of protein phosphatase 1b, a protein tyrosine phosphatase; diagnosis and antisense therapy of related diseases |
| 07/17/2001 | US6261836 Telomerase |
| 07/17/2001 | US6261834 Expression vector for site-specific integration and cell-specific gene expression; includes two inverted terminal repeats of adeno-associated virus 2 and a promoter linked to heterologous gene |
| 07/17/2001 | US6261832 Automated cell processor |
| 07/17/2001 | US6261807 Method for preparing a recombinant adenovirus genome |
| 07/17/2001 | US6261802 Ups (ugc) |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261791 Method for diagnosing cancer using specific PSCA antibodies |
| 07/17/2001 | US6261596 Method to provide for production of hair coloring pigments in hair follicles |
| 07/17/2001 | US6261559 Inhalation device |
| 07/17/2001 | US6261554 Compositions for targeted gene delivery |
| 07/17/2001 | US6261552 Genomes with deletion or mutation |
| 07/17/2001 | US6261551 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 07/12/2001 | WO2001050133A1 Gene expression in corneal diseases |
| 07/12/2001 | WO2001049885A1 EGS MOLECULES THAT SPECIFICALLY DOWNREGULATE bcl-xL EXPRESSION |
| 07/12/2001 | WO2001049869A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | WO2001049868A1 Cancer cell-specific gene expression system |
| 07/12/2001 | WO2001049861A1 A novel polypeptide, human spase i 13 and the polynucleotide encoding the polypeptide |
| 07/12/2001 | WO2001049844A1 Compositions and methods for gene silencing |
| 07/12/2001 | WO2001049829A1 Compositions and methods for efficient aav vector production |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049736A1 A new polypeptide-human rs3 protein and the polynucleotide encoding it |
| 07/12/2001 | WO2001049733A1 A novel polypeptide - glucosyl hydrolase 12 and a polynucleotide encoding the same |
| 07/12/2001 | WO2001049726A1 A novel polypeptide-human natriuretic peptide receptor 18 and the polynucleotide encoding said polypeptide |
| 07/12/2001 | WO2001049722A2 New actinobacillus pleuropneumoniae outer membrane protein and its uses |
| 07/12/2001 | WO2001049721A2 Bacterial genes and proteins that are essential for cell viability and their uses |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049325A2 Gene therapy to promote angiogenesis and/or the treatment of heart failure |
| 07/12/2001 | WO2001049324A2 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | WO2001049316A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 07/12/2001 | WO2001049118A1 Compositions comprising genome segments and methods of using the same |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | WO2001000220A3 Lipoprotein lipase (lpl) variant therapeutics |
| 07/12/2001 | WO2000075354A3 Adenoviral vectors encoding interferon and their use in gene therapy |
| 07/12/2001 | WO2000075321A3 Polynucleotides and membrane-bound polypeptide encoded thereby |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |